<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E7693B33-B414-465D-A3F7-3E442DCD8D59"><gtr:id>E7693B33-B414-465D-A3F7-3E442DCD8D59</gtr:id><gtr:name>Queen Mary University of London - Barts and the London School of Medicine &amp; Dentistry</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B75CE818-8A4C-4ACA-82E2-C952425212B2"><gtr:id>B75CE818-8A4C-4ACA-82E2-C952425212B2</gtr:id><gtr:name>Brainshake</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AB534209-3172-41E0-A85E-143F22107607"><gtr:id>AB534209-3172-41E0-A85E-143F22107607</gtr:id><gtr:name>Harvard School of Public Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Public Health and Primary Care</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E7693B33-B414-465D-A3F7-3E442DCD8D59"><gtr:id>E7693B33-B414-465D-A3F7-3E442DCD8D59</gtr:id><gtr:name>Queen Mary University of London - Barts and the London School of Medicine &amp; Dentistry</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B75CE818-8A4C-4ACA-82E2-C952425212B2"><gtr:id>B75CE818-8A4C-4ACA-82E2-C952425212B2</gtr:id><gtr:name>Brainshake</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AB534209-3172-41E0-A85E-143F22107607"><gtr:id>AB534209-3172-41E0-A85E-143F22107607</gtr:id><gtr:name>Harvard School of Public Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2A11538A-4A54-4A63-AB9F-BDB95AD7D61C"><gtr:id>2A11538A-4A54-4A63-AB9F-BDB95AD7D61C</gtr:id><gtr:firstName>Elio</gtr:firstName><gtr:surname>Riboli</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EB134AF9-197A-4970-8C8E-6D9132EBEB02"><gtr:id>EB134AF9-197A-4970-8C8E-6D9132EBEB02</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Ian</gtr:otherNames><gtr:surname>McCarthy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/161DE809-8AE4-4978-9F68-F106C8C63ED0"><gtr:id>161DE809-8AE4-4978-9F68-F106C8C63ED0</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Wareham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4B98F259-77FE-4FC0-9296-140C9C066977"><gtr:id>4B98F259-77FE-4FC0-9296-140C9C066977</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Danesh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D4875E5B-C2B2-4BB4-BA70-E1170A00D2A7"><gtr:id>D4875E5B-C2B2-4BB4-BA70-E1170A00D2A7</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Thompson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/95F764B3-B980-4210-87D7-B24034F7540A"><gtr:id>95F764B3-B980-4210-87D7-B24034F7540A</gtr:id><gtr:firstName>Leena</gtr:firstName><gtr:surname>Peltonen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D966BB61-3D36-4457-A5A8-2DE10449224D"><gtr:id>D966BB61-3D36-4457-A5A8-2DE10449224D</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Elliott</gtr:surname><gtr:orcidId>0000-0002-7511-5684</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C68F5417-E9B6-4D41-A185-16D809E144FD"><gtr:id>C68F5417-E9B6-4D41-A185-16D809E144FD</gtr:id><gtr:firstName>Petra</gtr:firstName><gtr:otherNames>Huberdina</gtr:otherNames><gtr:surname>Peeters</gtr:surname><gtr:orcidId>0000-0001-9030-8655</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0800270"><gtr:id>B49E45DD-B634-4825-9FD7-E75D0BAF95CA</gtr:id><gtr:title>Study of the interplay of genetic, biochemical, and lifestyle factors on coronary heart disease incidence</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800270</gtr:grantReference><gtr:abstractText>Heart disease is the single leading killer in the UK and globally, is responsible for considerable disability, and involves several important modifiable risk factors, such as smoking, diabetes, and elevated levels of cholesterol and blood pressure. 

The occurrence of heart attacks depends on the complex interplay of genetic make-up, environmental factors and chance. Understanding the interplay of ?nature? and ?nurture? in heart disease should contribute to important advances in: (i) explaining the biological chain of events that leads to a heart attack, (ii) effectively targeting existing measures to prevent disease, and (iii) developing lifestyle programmes for people to counteract disadvantageous genetic profiles. 

Until recently, it has been difficult to study the interplay of genes, biochemical factors and lifestyles (eg, dietary habits and physical activity) in CHD. Medical surveys have tended to be too small, insufficiently detailed, inappropriately designed, or had some combination of these limitations. Also, it is only in the past few years that genetic research has identified a reasonably large number of genetic factors related to heart disease and relevant characteristics (such as levels of blood fats, obesity and diabetes). 

The current research project seeks to conduct a large and detailed study of genetic, biochemical and lifestyle factors in heart disease by using an existing survey of over 500,000 middle-aged Europeans living in ten countries. Starting in the early 1990s, initially healthy participants gave blood, replied to questionnaires (eg, about lifestyles, habits) and provided physical measurements. These individuals have now been monitored for over a decade on average, during which time more than 10,000 people have had heart attacks. It is proposed to conduct genetic and biochemical tests in the stored samples of 10,000 patients with confirmed heart disease and in 10,000 controls who have remained free of heart disease. 

Genetic and biochemical information assessed in these individuals will then be collated with information on smoking habits, diet, physical activity and other characteristics previously recorded at the initial visit to create a rich and powerful database. This database will be carefully harvested to yield a series of immediate and longer-term findings of major international importance for the understanding, prediction and prevention of heart disease.</gtr:abstractText><gtr:technicalSummary>A strategic award is sought, jointly from the MRC and BHF, to enable large-scale investigation of the separate and combined influences of genetic, biochemical and major lifestyle factors (notably diet) on the incidence of coronary heart disease (CHD) in an existing large population-based prospective study across Europe. Reliable evaluation of the interplay of these factors should substantially advance understanding of the aetiology of CHD and contribute to prevention strategies, such as optimum targeting of interventions and identification of novel therapeutic targets. EPIC-Heart is in an excellent position to provide rapid, reliable and cost-effective studies of the combination of genetic, biochemical, and lifestyle factors because it has already: 

1) recorded, in a standardised and prospective manner, information on diet, physical activity and other lifestyle characteristics in almost 520,000 mostly middle-aged Europeans from 10 countries (with over ?100M invested to date to establish and maintain this cohort) 
2) collected and stored biological material to enable analyses of DNA, plasma and red cells 
3) accrued over 10,000 cases of incident CHD during over 5 million person-years of follow-up 
4) verified in a substudy that almost 90% of the patients in EPIC with suspected CHD fulfil standard criteria, and 
5) agreed and published a scientific plan and study management arrangements. 

EPIC-Heart will achieve further efficiency by utilising the 10,000 controls in the EPIC-InterAct case-cohort study of gene-lifestyle interactions in type 2 diabetes. InterAct has already been funded and will assay some risk markers of potential shared relevance to diabetes and CHD. Strategic support is sought, therefore, to enable an efficient case-cohort study of genetic, biochemical and lifestyle factors in CHD involving about 10,000 confirmed incident cases and 10,000 controls. This will entail: ascertainment and verification of CHD cases; retrieval of stored samples; extraction and preparation of DNA; focused genetic and biochemical assays; statistical analyses; and studies of implications of findings for clinical practice and population health. In addition to generating a series of exceptionally informative findings that address major current hypotheses in CHD, this initiative will create a unique resource for future investigations.</gtr:technicalSummary><gtr:fund><gtr:end>2015-01-04</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2977135</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brainshake</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>NMR Metabolomics</gtr:description><gtr:id>DDCB9CEA-EAA7-4455-80D1-AE42906BE60F</gtr:id><gtr:impact>Publication manuscripts in preparation</gtr:impact><gtr:partnerContribution>Assays complete for all 50,000 samples, ~240 metabolites measured.</gtr:partnerContribution><gtr:piContribution>Provided samples from 50,000 participants in INTERVAL study.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>B1CCAC6A-91BA-4783-AEE6-4D6E57DF0313</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>B5FD8F40-E435-4304-9825-5F271BD8B378</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck &amp; Co. Inc. (MSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>612551A2-EA74-4959-A505-4C286D34E145</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Global R &amp; D</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>8C7B0274-20A4-4D58-BFBB-FCE5C125A075</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>B9B3A850-F8F2-4836-A43B-C421530CA823</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London - Barts and the London School of Medicine &amp; Dentistry</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>74BD7541-7A50-4731-949A-9CB5CC6735EF</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard School of Public Health</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>B33E0C23-3F3F-48E8-911F-E8AFC6AC17B1</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation at BRC Scientific Advisory Board</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A5D2D490-A508-4CEE-B953-1FAEEB52CA61</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>47D43830-64E9-4918-91D1-D5CE90F70668</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at BHF Centre of Excellence meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D30BD8BD-720D-436A-8CA4-DAB54BF90073</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the European Bioinformatics Institute</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>51292310-7B4A-422F-9E7A-AF668FFABFBA</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at Wellcome Trust Target Validation Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>439C2D97-ED0D-480D-BD84-97E356686F00</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to Takeda</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>814E5F4F-CAF3-4A13-821D-DEB84DFA9659</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Collaborative workshop MRC Biostatistics</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4A73919D-EF1E-4A03-9658-543ABBEE273E</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at AstraZeneca</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AEC5D016-46F5-43EB-B7A5-731027BA8A01</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alan Turing Institute presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>662E0B0B-6110-41C1-8936-921562A022B4</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2499154</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>European Research Council Advanced Investigator Award (EPIC Heart)</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>EECA9F3E-A4B5-4D0E-8EF8-F2EAC8780C24</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4099619</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>Blood Transplant Research Unit (NIHR - BTRU)</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>D2E51A21-63F3-4EA1-A6EF-FF1FB4048AAF</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EPIC-CVD (Framework Programme 7 - Health)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>815E66CB-FE1B-4777-A6A5-E9FA1CC3883E</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Exome chip consortium</gtr:description><gtr:id>663E61CD-282C-4607-9508-B0EF7CE19478</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Exome Chip Consortium</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Data have been collected and harmonised on 25,000 individuals</gtr:description><gtr:id>FB9D3EF7-18D8-4CDA-B417-EDD24B619060</gtr:id><gtr:impact>No impact as yet</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EPIC-Heart Database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>The EPIC-Heart phenotype database is being expanded to stroke outcomes (~9000 incident cases), rather than just coronary disease, adding further value to the initial investment</gtr:description><gtr:id>2AD31D2C-0D98-4ADD-863A-88C7E5A65594</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EPIC-CVD database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Metabochip Consortium database</gtr:description><gtr:id>075F2E05-C955-4D64-B6D6-92784259EDE9</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Metabochip Consortium</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Assays have now been completed in all EPIC-Heart participants on the following phenotypes:
- 22 clinical chemistry biomarkers
- 210,000 genetic variants
- a further 450,000 genetic variants
- a panel of 37 fatty acids

Assays are near completion in these participants for vitamins C and D, a panel of 6 carotenoids and telomere length. These assays are also being extended to stroke cases identified under the FP7 funded project, EPIC-CVD, adding further value to the EPIC-Heart project.</gtr:description><gtr:id>55D4943B-8429-4A40-8EAD-1D6AC4994D76</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EPIC-Heart Assays</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>To allow the assessment of risk prediction in a multi-centre case-cohort study, novel statistical methods have been developed at the EPIC-Heart Coordinating Centre</gtr:description><gtr:id>47DD75EB-6EAE-4D76-8501-68FAE92A7DB4</gtr:id><gtr:impact>A Publication: &amp;quot;Derivation and assessment of risk prediction models using case-cohort data&amp;quot;. Sanderson J, Thompson SG, White IR, Aspelund T, Pennells L. BMC Med Res Methodol. 2013 Sep 13;13(1):113</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Methods</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AC102729-DBE9-47F8-97FB-485C1930B7A5"><gtr:id>AC102729-DBE9-47F8-97FB-485C1930B7A5</gtr:id><gtr:title>Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature.</gtr:title><gtr:parentPublicationTitle>The European journal of health economics : HEPAC : health economics in prevention and care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e5ddbd88c7baa76c088b9c1561fcd4e"><gtr:id>1e5ddbd88c7baa76c088b9c1561fcd4e</gtr:id><gtr:otherNames>Epstein D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1618-7598</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CEC685E0-2EFE-4457-9966-609155D9F6C4"><gtr:id>CEC685E0-2EFE-4457-9966-609155D9F6C4</gtr:id><gtr:title>Association of Cardiometabolic Multimorbidity With Mortality.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/00954130f581451305ebfe461866731f"><gtr:id>00954130f581451305ebfe461866731f</gtr:id><gtr:otherNames>Emerging Risk Factors Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E620BE1D-D5AB-4B0D-A87D-6379BBC9CA06"><gtr:id>E620BE1D-D5AB-4B0D-A87D-6379BBC9CA06</gtr:id><gtr:title>Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/912b30d31656b2b1028d2418b3ec3190"><gtr:id>912b30d31656b2b1028d2418b3ec3190</gtr:id><gtr:otherNames>Singh T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8F88AE31-62C8-41CA-B61D-10E322969692"><gtr:id>8F88AE31-62C8-41CA-B61D-10E322969692</gtr:id><gtr:title>A method making fewer assumptions gave the most reliable estimates of exposure-outcome associations in stratified case-cohort studies.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7e050bd6475c7c807ec5722cb9a2cc56"><gtr:id>7e050bd6475c7c807ec5722cb9a2cc56</gtr:id><gtr:otherNames>Jones E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4AAB7709-F7B8-49AF-8208-8D728CE5AF12"><gtr:id>4AAB7709-F7B8-49AF-8208-8D728CE5AF12</gtr:id><gtr:title>Bias due to participant overlap in two-sample Mendelian randomization.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7FB93BE7-4D24-4A7D-A0EB-EAC1501966B0"><gtr:id>7FB93BE7-4D24-4A7D-A0EB-EAC1501966B0</gtr:id><gtr:title>Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02bac0ee896543d3e23e64b1b65f0d59"><gtr:id>02bac0ee896543d3e23e64b1b65f0d59</gtr:id><gtr:otherNames>Sifrim A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3969E64E-F06E-4202-A846-05D1130F9D9E"><gtr:id>3969E64E-F06E-4202-A846-05D1130F9D9E</gtr:id><gtr:title>The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3227fce97d99562f294f215341e71f74"><gtr:id>3227fce97d99562f294f215341e71f74</gtr:id><gtr:otherNames>Astle WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92F5C8D2-DC30-4B56-8B5E-ACF6A0E7235E"><gtr:id>92F5C8D2-DC30-4B56-8B5E-ACF6A0E7235E</gtr:id><gtr:title>Comparative validity of vitamin C and carotenoids as indicators of fruit and vegetable intake: a systematic review and meta-analysis of randomised controlled trials.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/783a1a1910d70519c37242956f10c439"><gtr:id>783a1a1910d70519c37242956f10c439</gtr:id><gtr:otherNames>Pennant M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/996FC8D3-6EEE-4D49-B7A8-0AB8D42B62F1"><gtr:id>996FC8D3-6EEE-4D49-B7A8-0AB8D42B62F1</gtr:id><gtr:title>Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02f4cefb1b43fd90206d810c05991f5d"><gtr:id>02f4cefb1b43fd90206d810c05991f5d</gtr:id><gtr:otherNames>Silarova B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E5133FF2-FD75-4E02-900F-1B332AD1458F"><gtr:id>E5133FF2-FD75-4E02-900F-1B332AD1458F</gtr:id><gtr:title>Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb094f6bdc37c8484868410c6dce353d"><gtr:id>eb094f6bdc37c8484868410c6dce353d</gtr:id><gtr:otherNames>Kato N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C9341571-6527-45AC-82AB-DA89AFF62AA5"><gtr:id>C9341571-6527-45AC-82AB-DA89AFF62AA5</gtr:id><gtr:title>Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/471BA0D2-6589-43FC-8A44-EF291E12D63C"><gtr:id>471BA0D2-6589-43FC-8A44-EF291E12D63C</gtr:id><gtr:title>Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6239da935471ebe92e7c1c0a9617342b"><gtr:id>6239da935471ebe92e7c1c0a9617342b</gtr:id><gtr:otherNames>Imamura M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43D5EEAA-FEC0-4E56-8FDC-6904A62562DF"><gtr:id>43D5EEAA-FEC0-4E56-8FDC-6904A62562DF</gtr:id><gtr:title>Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6c738f04b064217a6a3e4b8447dddfc9"><gtr:id>6c738f04b064217a6a3e4b8447dddfc9</gtr:id><gtr:otherNames>Usher-Smith JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/55890CB9-62FA-4457-A8DF-ACA6D6FB3AB7"><gtr:id>55890CB9-62FA-4457-A8DF-ACA6D6FB3AB7</gtr:id><gtr:title>Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e4c220c3b3958f29fccb7c03f12eb86"><gtr:id>4e4c220c3b3958f29fccb7c03f12eb86</gtr:id><gtr:otherNames>Interleukin 1 Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B15A05B-03F4-4D3D-9758-EDB84DB7EAC9"><gtr:id>7B15A05B-03F4-4D3D-9758-EDB84DB7EAC9</gtr:id><gtr:title>Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F34E6CB-EE71-4714-91FB-91AD063B0B06"><gtr:id>3F34E6CB-EE71-4714-91FB-91AD063B0B06</gtr:id><gtr:title>The genetic architecture of type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02f1c0ac4ac1ce215e6ad458834e0672"><gtr:id>02f1c0ac4ac1ce215e6ad458834e0672</gtr:id><gtr:otherNames>Fuchsberger C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8532939C-043A-410F-96CD-35D1CCF713E0"><gtr:id>8532939C-043A-410F-96CD-35D1CCF713E0</gtr:id><gtr:title>Assessing risk prediction models using individual participant data from multiple studies.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/06604b6e3b810c3a3d29dc9dc30fa1d9"><gtr:id>06604b6e3b810c3a3d29dc9dc30fa1d9</gtr:id><gtr:otherNames>Pennells L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7AAE0E77-C2CE-467E-9F3A-76AF80DAD78A"><gtr:id>7AAE0E77-C2CE-467E-9F3A-76AF80DAD78A</gtr:id><gtr:title>Increased DNA methylation variability in type 1 diabetes across three immune effector cell types.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b159c2fdc40bd9f1b680388b2982bc9d"><gtr:id>b159c2fdc40bd9f1b680388b2982bc9d</gtr:id><gtr:otherNames>Paul DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68A806B0-7FB9-4936-8293-8E820C336ECF"><gtr:id>68A806B0-7FB9-4936-8293-8E820C336ECF</gtr:id><gtr:title>A review of published analyses of case-cohort studies and recommendations for future reporting.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02cdd1b81d6df42a82ec19819c9751dd"><gtr:id>02cdd1b81d6df42a82ec19819c9751dd</gtr:id><gtr:otherNames>Sharp SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3A22DC1-4ED6-40E6-9BC6-DBD45E724CB0"><gtr:id>E3A22DC1-4ED6-40E6-9BC6-DBD45E724CB0</gtr:id><gtr:title>Accuracy of Patient Self-Report of Stroke: A Systematic Review from the UK Biobank Stroke Outcomes Group.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bc177bc67084e61937ac7f2b418f0334"><gtr:id>bc177bc67084e61937ac7f2b418f0334</gtr:id><gtr:otherNames>Woodfield R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8AB2B03C-DBFD-4762-A380-5DE7613A1574"><gtr:id>8AB2B03C-DBFD-4762-A380-5DE7613A1574</gtr:id><gtr:title>Parity, breastfeeding and risk of coronary heart disease: A pan-European case-cohort study.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7daee98c7d288fe9d8420024484dc3e"><gtr:id>b7daee98c7d288fe9d8420024484dc3e</gtr:id><gtr:otherNames>Peters SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5B30460-E7F9-4842-BF51-5223CCDB9503"><gtr:id>A5B30460-E7F9-4842-BF51-5223CCDB9503</gtr:id><gtr:title>The genetic architecture of type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02f1c0ac4ac1ce215e6ad458834e0672"><gtr:id>02f1c0ac4ac1ce215e6ad458834e0672</gtr:id><gtr:otherNames>Fuchsberger C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F19B3E3-6E27-4379-B4D7-D3B13FC22EAE"><gtr:id>5F19B3E3-6E27-4379-B4D7-D3B13FC22EAE</gtr:id><gtr:title>Derivation and assessment of risk prediction models using case-cohort data.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d9829eb284f15497e3e21d2a57302b4"><gtr:id>2d9829eb284f15497e3e21d2a57302b4</gtr:id><gtr:otherNames>Sanderson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC58626D-C199-411D-A379-F6A39F655580"><gtr:id>DC58626D-C199-411D-A379-F6A39F655580</gtr:id><gtr:title>Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7e395f3d1d4bf26598536bd293a9e4b"><gtr:id>f7e395f3d1d4bf26598536bd293a9e4b</gtr:id><gtr:otherNames>Podmore C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800270</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>